Display options
Share it on

Curr Opin Endocrinol Diabetes. 2006 Dec 01;13(6):497-502. doi: 10.1097/MED.0b013e3280109b6c.

Low bone-mineral density in patients with HIV: pathogenesis and clinical significance.

Current opinion in endocrinology & diabetes

Michael T Yin, Elizabeth Shane

Affiliations

  1. Department of Medicine, Division of Infectious Diseases, Columbia University, College of Physicians and Surgeons, New York, New York, USA.

PMID: 20467568 PMCID: PMC2868191 DOI: 10.1097/MED.0b013e3280109b6c

Abstract

PURPOSE OF REVIEW: Low bone-mineral density is a recently recognized metabolic complication of HIV infection and its treatment. While the clinical impact of low bone-mineral density remains uncertain, the prolongation of survival attributable to more effective antiretroviral therapy has contributed to an aging population of HIV-infected patients who may be prone to developing fragility fractures. RECENT FINDINGS: While most of the available data are on young men, recent publications have increased our understanding of the epidemiology of low bone-mineral density and bone loss in HIV-positive women. Most studies suggest that initiation of certain combinations of antiretroviral agents may be associated with moderate bone loss initially, but bone-mineral density usually stabilizes or improves with longer follow-up. Most studies suggest that, despite lower bone-mineral density, fragility fractures are relatively uncommon in HIV-positive patients, perhaps because of their relative youth. SUMMARY: The pathogenesis of low bone-mineral density in HIV-positive patients is complex and multifactorial, and its clinical impact remains unclear. Further research is needed to clarify the approach to optimal screening and treatment of osteoporosis in the setting of HIV infection.

References

  1. Am J Clin Nutr. 2001 Nov;74(5):679-86 - PubMed
  2. Bone. 1995 Feb;16(2):185-91 - PubMed
  3. Clin Infect Dis. 2003 Feb 15;36(4):482-90 - PubMed
  4. AIDS Res Hum Retroviruses. 1994 Apr;10(4):391-4 - PubMed
  5. J Clin Endocrinol Metab. 1999 Jan;84(1):145-50 - PubMed
  6. AIDS. 2001 Jul 6;15(10):1275-80 - PubMed
  7. HIV Clin Trials. 2004 Sep-Oct;5(5):269-77 - PubMed
  8. Virology. 1995 Apr 20;208(2):779-83 - PubMed
  9. J Intern Med. 1999 Jan;245(1):69-73 - PubMed
  10. AIDS. 2003 Mar 7;17(4):513-20 - PubMed
  11. Osteoporos Int. 2005 Nov;16(11):1345-52 - PubMed
  12. AIDS. 1999 Dec 24;13(18):2605-6 - PubMed
  13. Clin Infect Dis. 2004 Jan 15;38(2):263-70 - PubMed
  14. Ann Intern Med. 1986 Jul;105(1):37-44 - PubMed
  15. J Biol Chem. 2002 Nov 15;277(46):44347-56 - PubMed
  16. J Clin Invest. 2003 Apr;111(8):1221-30 - PubMed
  17. J Clin Endocrinol Metab. 2006 Aug;91(8):2938-45 - PubMed
  18. HIV Med. 2002 Apr;3(2):85-90 - PubMed
  19. J Infect. 2003 May;46(4):221-7 - PubMed
  20. AIDS. 2004 Feb 20;18(3):475-83 - PubMed
  21. AIDS. 2003 Sep 5;17(13):1917-23 - PubMed
  22. J Immunol. 1990 Jan 15;144(2):480-4 - PubMed
  23. Ann Intern Med. 1991 Nov 1;115(9):665-73 - PubMed
  24. J Bone Miner Res. 2001 Jan;16(1):2-9 - PubMed
  25. Vitam Horm. 1996;52:63-98 - PubMed
  26. J Biol Chem. 2003 Nov 28;278(48):48251-8 - PubMed
  27. J Clin Endocrinol Metab. 2001 May;86(5):2020-6 - PubMed
  28. J Clin Endocrinol Metab. 1997 May;82(5):1332-7 - PubMed
  29. AIDS. 2001 May 25;15(8):975-82 - PubMed
  30. Bone. 1995 Aug;17(2 Suppl):63S-67S - PubMed
  31. AIDS. 1990 Jun;4(6):527-35 - PubMed
  32. N Engl J Med. 1995 Feb 2;332(5):305-11 - PubMed
  33. Calcif Tissue Int. 1993;53 Suppl 1:S94-8 - PubMed
  34. J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):426-31 - PubMed
  35. J Bone Miner Res. 1996 Aug;11(8):1043-51 - PubMed
  36. J Int Assoc Physicians AIDS Care (Chic). 2004 Jul-Sep;3(3):86-91 - PubMed
  37. Boll Soc Ital Biol Sper. 1995 Sep-Oct;71(9-10):275-9 - PubMed
  38. J Infect Dis. 2001 Nov 15;184(10):1325-7 - PubMed
  39. AIDS. 2003 May 2;17(7):971-9 - PubMed
  40. Calcif Tissue Int. 1997 Jul;61(1):30-2 - PubMed
  41. Am J Med. 1988 Sep;85(3):289-91 - PubMed
  42. J Clin Endocrinol Metab. 1998 Sep;83(9):3050-5 - PubMed
  43. Curr Opin Rheumatol. 2003 Jul;15(4):454-7 - PubMed
  44. Metabolism. 2000 Sep;49(9):1134-9 - PubMed
  45. J Clin Endocrinol Metab. 2001 Aug;86(8):3533-9 - PubMed
  46. J Clin Endocrinol Metab. 1998 Nov;83(11):3832-8 - PubMed
  47. JAMA. 2001 Feb 14;285(6):785-95 - PubMed
  48. AIDS. 2001 Apr 13;15(6):703-9 - PubMed
  49. AIDS. 2001 Jan 5;15(1):137-8 - PubMed
  50. Bone. 1999 Apr;24(4):381-5 - PubMed
  51. AIDS. 2001 Sep 7;15(13):1731-3 - PubMed
  52. Endocrinology. 1999 Sep;140(9):4367-70 - PubMed
  53. AIDS. 2000 Mar 10;14(4):F63-7 - PubMed
  54. J Clin Endocrinol Metab. 2004 Mar;89(3):1200-6 - PubMed
  55. J Appl Physiol (1985). 2001 Jun;90(6):2166-71 - PubMed
  56. Int J Immunopharmacol. 1995 Feb;17(2):109-16 - PubMed
  57. J Acquir Immune Defic Syndr. 2002 May 1;30(1):131-2 - PubMed
  58. AIDS. 2005 Jul 22;19(11):1240-1 - PubMed
  59. JAMA. 1984 Sep 7;252(9):1152-9 - PubMed
  60. J Biol Chem. 2002 May 31;277(22):19247-50 - PubMed
  61. Clin Infect Dis. 2002 Aug 15;35(4):475-81 - PubMed
  62. Horm Res. 1995;44(1):35-9 - PubMed
  63. Semin Hematol. 2001 Jul;38(3):276-85 - PubMed
  64. J Acquir Immune Defic Syndr (1988). 1992;5(8):841-6 - PubMed
  65. Acta Paediatr. 2003;92(1):12-6 - PubMed
  66. Infection. 1993 Jul-Aug;21(4):220-2 - PubMed
  67. J Clin Invest. 2004 Jul;114(2):206-13 - PubMed
  68. Clin Infect Dis. 2006 Apr 1;42(7):1014-20 - PubMed

Publication Types

Grant support